Do I Need to Increase My Mounjaro Dose?

Mounjaro is prescribed at six strengths (2.5mg to 15mg); titration is gradual and led by how you tolerate each dose, not by a fixed calendar.
The starting 2.5mg dose exists to let your body adjust, not to drive weight loss, many people feel little effect at first, and that's expected.
Side effects at the current dose, or a plateau in weight loss after several months at the highest tolerated dose, are two different triggers for a prescriber conversation.
A prescriber must review your case before any change; self-adjusting your dose is unsafe and outside the terms of any legitimate prescription.

Whether a Mounjaro dose increase is right for you is a clinical decision, not a personal one you should make alone. Most people do move through the dose schedule over time, but the timing depends on how your body is responding, not on hitting a fixed number of weeks. These are prescription-only medicines, and every dose change needs a prescriber's sign-off. Here's what the evidence says about when — and why — titration happens.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What actually drives titration decisions on Mounjaro, and what doesn't

The myth: if you're not losing weight quickly, you need a higher dose

This is the most common misunderstanding our prescribers hear. The belief goes: more medicine equals more effect, so if the scales aren't moving fast enough, the next dose up must be the answer. In practice, it's more complicated than that.

Mounjaro's titration schedule exists primarily to manage tolerability, not to dial up results week by week. The 2.5mg pen that starts treatment is there to settle your system, nausea, indigestion and fatigue are significantly more common when the dose climbs too fast. Moving up before your body has adapted tends to make side effects worse without meaningfully improving outcomes.

Weight loss on tirzepatide also doesn't always track the dose in a straight line. Many people notice a plateau for a few weeks, then further change. Eating patterns, sleep, stress and activity all interact with how the medicine works. If you're several weeks into a dose and feeling well-tolerated but discouraged by slower progress, that's worth discussing with your prescriber, not a reason to self-escalate. You can read more about why hunger sometimes persists in the early weeks, which often surprises people who expected immediate appetite change.

When a dose increase is genuinely the right conversation to have

There are situations where moving to the next strength is clinically appropriate, and your prescriber will consider a few things together.

First, tolerability at the current dose. If you've been on a given strength for at least four weeks and side effects have settled to a manageable level, you're in the window where titration makes sense. The timing of when to increase a Mounjaro dose is typically guided by four-week steps, though some people stay longer at a particular strength if they're still experiencing GI symptoms.

Second, response over time. NICE's appraisal of tirzepatide notes that if someone hasn't achieved at least 5% weight loss after six months at the highest dose they can tolerate, continuing treatment is reviewed rather than automatically continued. That's a long horizon, it's not a reason to rush titration early, but it does mean the direction of travel matters. The full Mounjaro overview covers the licensed weight-management evidence in more detail.

Third, the specific dose you're on. The 5mg dose, for instance, is both a titration step and the first dose that many people consider genuinely therapeutic, what to expect at 5mg is a question worth understanding before assuming you need more.

Side effects that make the case for slowing down, not speeding up

If you're asking whether you need to increase your Mounjaro dose because you're feeling unwell on your current one, the answer is almost certainly: not yet. Persistent nausea, vomiting, or diarrhoea that hasn't eased within two weeks of a dose change is a signal to stay where you are or talk to your prescriber about whether a step back is right. Some people find a lower dose actually produces better long-term outcomes because they can stick with it.

For side effects specifically tied to the starting strength, the side effects at 2.5mg are worth understanding separately, this dose affects people differently from higher ones.

The NHS patient information for tirzepatide describes the full side-effect profile and which symptoms warrant urgent medical attention, including the NHS tirzepatide page. Severe stomach pain that spreads to the back, with or without vomiting, should be assessed urgently, this can be a sign of pancreatitis, which the MHRA highlighted in a 2026 safety communication for GLP-1 medicines.

How dose decisions work at a regulated pharmacy (and why that matters for cost

At a GPhC-registered pharmacy like ours, a named prescriber) not an automated system, reviews your progress before authorising a dose change. That applies to every repeat, not just the first one. If you're transferring from another provider or requesting a higher strength, evidence of your current treatment and recent weight is required. That might feel like extra steps, but it's what clinical governance looks like in practice.

It's worth knowing that higher doses cost more per pen, and the difference between a 2.5mg and 12.5mg pen can be significant. Understanding Mounjaro's cost structure in the UK is genuinely useful context, especially if you're planning several months of treatment. One transparent price at each dose level, no subscription, no hidden fees, that's how it should work. Find out about the weight-loss treatments available through a regulated service if you're still weighing your options.

There's an honest question underneath all of this: whether increasing your Mounjaro dose is the right move depends entirely on your individual picture, which is exactly what a prescriber conversation is for. Nobody knows your response to treatment better than the clinician who has followed your progress. That conversation is also the right place to ask about why dose increases are built into the treatment model in the first place.

If you're unsure where you stand, speak to our prescribers, a free consultation is the starting point.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions